The trademark application MOLREC was filed by Recursion Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 12, 2023, and it was registered by office on July 20, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 42 with Providing scientific research information and results in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding from an online searchable database and Providing scientific research information and results in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding..